
21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
21.01.2020
3D Genomemedicine Inc is going to operate in USA
2 More kits with CE: Ureaplasma urealyticum ready to use PCR kit and cDNA positive control for Influenza H5 (total number of kits with CE are 17 now).